ArticleSensors (Basel, Switzerland)2021
Sensor Validation and Diagnostic Potential of Smartwatches in Movement Disorders.
Article in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Movement Disorders and Smart Wrist Devices: A Comprehensive Study.Sensors (Basel, Switzerland) · 2025Pooled it
- Machine learning and wearable sensors for automated Parkinson's disease diagnosis aid: a systematic review.Journal of neurology · 2024Pooled it
- Evaluating Web Retrieval-Assisted Large Language Models With and Without Whitelisting for Evidence-Based Neurology: Comparative Study.Journal of medical Internet research · 2025Article
- Applications of flexible materials in health management assisted by machine learning.RSC advances · 2025Review
- Smartwatch Versus Routine Tremor Documentation: Descriptive Comparison.JMIR formative research · 2024Article
- Upper limb intention tremor assessment: opportunities and challenges in wearable technology.Journal of neuroengineering and rehabilitation · 2024Review
- Machine Learning in the Parkinson's disease smartwatch (PADS) dataset.NPJ Parkinson's disease · 2024Article
- Smartwatches in healthcare medicine: assistance and monitoring; a scoping review.BMC medical informatics and decision making · 2023Article
- Utilizing a tablet-based artificial intelligence system to assess movement disorders in a prospective study.Scientific reports · 2023Article
- "suMus," a novel digital system for arm movement metrics and muscle energy expenditure.Frontiers in physiology · 2023Article
- Monipar: movement data collection tool to monitor motor symptoms in Parkinson's disease using smartwatches and smartphones.Frontiers in neurology · 2023Article
- Diagnosis and Treatment of Tremor in Parkinson's Disease Using Mechanical Devices.Life (Basel, Switzerland) · 2022Review
- Step-Counting Accuracy of a Commercial Smartwatch in Mild-to-Moderate PD Patients and Effect of Spatiotemporal Gait Parameters, Laterality of Symptoms, Pharmacological State, and Clinical Variables.Sensors (Basel, Switzerland) · 2022Article
- Smart Consumer Wearables as Digital Diagnostic Tools: A Review.Diagnostics (Basel, Switzerland) · 2022Review
- Editorial: AI-powered advances in diagnosis and management of movement disorders.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Smartwatches provide technology-based assessments in Parkinson's Disease (PD). It is necessary to evaluate their reliability and accuracy in order to include those devices in an assessment. We present unique results for sensor validation and disease classification via machine learning (ML). A comparison setup was designed with two different series of Apple smartwatches, one Nanometrics seismometer and a high-precision shaker to measure tremor-like amplitudes and frequencies. Clinical smartwatch measurements were acquired from a prospective study including 450 participants with PD, differential diagnoses (DD) and healthy participants. All participants wore two smartwatches throughout a 15-min examination. Symptoms and medical history were captured on the paired smartphone. The amplitude error of both smartwatches reaches up to 0.005 g, and for the measured frequencies, up to 0.01 Hz. A broad range of different ML classifiers were cross-validated. The most advanced task of distinguishing PD vs. DD was evaluated with 74.1% balanced accuracy, 86.5% precision and 90.5% recall by Multilayer Perceptrons. Deep-learning architectures significantly underperformed in all classification tasks. Smartwatches are capable of capturing subtle tremor signs with low noise. Amplitude and frequency differences between smartwatches and the seismometer were under the level of clinical significance. This study provided the largest PD sample size of two-hand smartwatch measurements and our preliminary ML-evaluation shows that such a system provides powerful means for diagnosis classification and new digital biomarkers, but it remains challenging for distinguishing similar disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.